Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro
eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleMethods/New Tools, Novel Tools and Methods

An ATF3-CreERT2 Knock-In Mouse for Axotomy-Induced Genetic Editing: Proof of Principle

Seth D. Holland, Leanne M. Ramer, Stephen B. McMahon, Franziska Denk and Matt S. Ramer
eNeuro 28 March 2019, 6 (2) ENEURO.0025-19.2019; https://doi.org/10.1523/ENEURO.0025-19.2019
Seth D. Holland
1International Collaboration on Repair Discoveries, the University of British Columbia, Vancouver, British Columbia, Canada V5Z 1M9
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leanne M. Ramer
2Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, British Columbia, Canada V5A 1S6
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen B. McMahon
3Wolfson Centre for Age-Related Diseases, King’s College London, London, United Kingdom SE1 1UL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stephen B. McMahon
Franziska Denk
3Wolfson Centre for Age-Related Diseases, King’s College London, London, United Kingdom SE1 1UL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Franziska Denk
Matt S. Ramer
1International Collaboration on Repair Discoveries, the University of British Columbia, Vancouver, British Columbia, Canada V5Z 1M9
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Axotomy-induced recombination in peripherally-projecting neurons. A, Validation of an ATF3-specific antibody. The Novus antibody (NBP1-85816) produces a positive signal in nuclei of axotomized sensory neurons in ATF3+/+ mice, but not ATF3cre/cre mice. Note that the Santa Cruz antibody (C-19) labels neuronal nuclei in in the latter (inset), indicating non-specific staining. B, C, Axotomy induced reporter expression in sensory (DRG), sympathetic (stellate ganglion, SG), and motoneurons 4 d after injury. D, Reporter expression in sensory axons and motoneurons one week after injury. E, Preventing CreERT2 translocation from cytoplasm to nucleus with ICI 182780 reduces recombination in ATF3+ cells (by ∼50%). F, Recombination efficiency 16 d after injury was calculated by expressing the proportion of tracer-filled somata (labeled at the time of injury) that were also reporter (tdtomato)-positive. G, Recombination efficiencies at 4 and 16 d after injury (n = 3 for each time point) for DRG and motoneurons. Images in panels A, B, E were taken from whole mounts, those in C, D, F from cryosections.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Axotomy does not induce ATF3 in Schwann cells. A, Cryosections from injured DRG (inset) and distal sciatic nerve from the same mouse processed for ATF3 immunohistochemistry (Novus NBP1-85816). B, Punctate staining in the nerve proved to be non-specific fluorescence of leukocytes (note non-nuclear signal in the absence of primary antibody). C, In intact sciatic nerves, cells morphologically identical to Remak cells had at some point undergone recombination. D, Following injury, their numbers increased. E, This was attributable to their proliferation in the injured nerve (as opposed to ATF3 induction and subsequent recombination). C′, D′, Magnification of areas outlined in C and D demonstrate the spindle shaped morphology characteristic of Remak cells.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Loss of ATF3 function delays functional recovery following sciatic nerve crush. A, B, The rate of functional recovery (nocifensive reflex withdrawal to a toe pinch and presence of any grasping ability) was reduced in mice lacking both wild-type ATF3 alleles (log rank Mantel–Cox test). Haploinsufficiency was also suggested by the statistically-significant trend from wild-type to homozygous knock-in (log rank Mantel–Cox test), n = 7, n = 9, and n = 8 for ATF3+/+, ATF3+/cre, and ATF3cre/cre, respectively. C, Representative EMG traces from ipsilateral and contralateral sides of an ATF3+/+ mouse 28 d after sciatic nerve crush, and composite traces from seven ATF3+/+ mice and seven ATF3cre/cre mice. D, EMG thresholds did not differ between genotypes (paired t test). E, F, While absolute latencies and amplitudes did not differ between genotypes (paired t test), their ipsilateral/contralateral ratios (correcting for mouse size) indicated reduced conduction velocity (E) and extent of reinnervation (F) in mice lacking one or both wild-type ATF3 alleles (unpaired t test), n = 6, n = 7, and n = 6 for ATF3+/+, ATF3+/cre, and ATF3cre/cre, respectively.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Loss of ATF3 function modestly reduces axonal regeneration following sciatic nerve crush. A, B, There was no difference in axonal regeneration 2 d following injury between ATF3+/+, ATF3+/cre, and ATF3cre/cre mice (n = 7, n = 6, and n = 6, respectively, groups were compared with a one-way ANOVA on cumulative densities). C, D, ATF3cre/cre mice exhibited significantly diminished axonal regeneration 3 d following injury 2–4 mm distal to the injury compared to ATF3+/+ mice (n = 5 for both groups, one-way ANOVA followed by Dunnett’s multiple comparison test). The hemizygous group (n = 4) tested positive as a significant intermediary between both control and ATF3 null groups (post hoc test for trend). Dotted line indicates distal border of crush site, 500 μm from the edge of the block. Scale bars: 500 μm.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Axotomy-induced PTEN deletion in sensory and motoneurons. A, B, Axotomy results in significant loss of PTEN expression in the DRG. Arrows in A indicate small PTEN-positive DRG neurons. The PTEN antibody results in high background staining in all animals, to which PTEN immunoreactivity is reduced in axotomized DRGs of ATF3+/cre:PTENfl/fl mice (B; one-way ANOVA followed by Dunnett’s multiple comparison test, n = 5 for both groups). C, PTEN immunoreactivity is weak in all motoneurons, rendering difficult confirmation of axotomy-induced knock-down. However, ventral root (VR; large arrow) axons close to the ventral root exit zone were intensely immunopositive, single arrows indicate axons that were both tdtomato and PTEN positive, whereas double arrows indicate recombination without PTEN immunoreactivity. In sections of ventral roots, we were able to demonstrate a significant decrease in PTEN immunoreactivity in tdtomato-positive axons (D; Kolmogorov–Smirnov goodness of fit test), n = 4 and n = 3 for ATF3+/cre:PTEN+/+ and ATF3+/cre:PTENfl/fl, respectively. Scale bars: 50 μm (A), 100 μm (C), 10 μm (E).

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Axotomy-induced PTEN deletion and improves functional recovery following sciatic nerve crush. A, B, While there was no difference in recovery of reflex nociception or grasping in mice with floxed PTEN alleles (log rank Mantel–Cox test, n = 14 and n = 9 for ATF3+/cre:PTEN+/+ and ATF3+/cre:PTENfl/fl, respectively), EMG responses (C–G) indicated enhanced recovery of neuromuscular function. C, D, Representative EMG traces from ipsilateral and contralateral sides of an ATF3+/cre:PTEN+/+ mouse 28 d after sciatic nerve crush (C) and composite traces from eight ATF3+/cre:PTEN+/+ mice and six ATF3cre/cre:PTENfl/fl mice. E–G, Ipsilateral/contralateral ratios of EMG thresholds (E), peak EMG latencies (F), and maximum CMAP amplitudes (G) all indicated more complete muscle reinnervation 28 d after injury; n = 8 and n = 6 for ATF3+/cre:PTEN+/+ and ATF3+/cre:PTENfl/fl, respectively, averages were compared using paired t tests and ipsilateral/contralateral ratios with unpaired t tests.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    Axotomy-induced PTEN deletion and anatomic regeneration following sciatic nerve crush. A, B, Axonal regeneration 2 d subsequent to sciatic nerve crush (dotted line) was significantly enhanced in ATF3+/cre:PTENfl/fl mice. In C, bar graphs represent the cumulative density of SCG10 immunoreactivity from 0 μm (the distal extent of the crush site) to 2000 μm; n = 6 for both groups and cumulative densities were compared using an unpaired t test. Scale bars: 500 μm.

  • Figure 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 8.

    Axotomy-induced recombination one week following spinal hemisection: spinal cord. A, Two examples of the injury site from separate animals in longitudinal section. Insets show consistently-recombining ipsilaterally-projecting neurons near Clarke’s column below the injury. B, Cartoon of transverse section of the hemisected spinal cord illustrating relative positions of positionally and morphologically distinguishable recombined neurons (colored dots correspond to examples in C–F). C, Examples of recombination after injury in cervical (top left), lumbar (two examples middle and bottom-left), and thoracic (top right). The most consistent findings were small ipsilaterally-projecting neurons in the thoracic cord (C’), and large neurons contralateral to injury from just lateral to area X to the ventral gray matter in the lumbar cord (C’’). Arrows in C’, C’’ indicate midline-crossing axons. Arrow pointing to tdtomato+ axons in dorsal cervical white matter indicates probable rubrospinal (RST) and/or raphespinal tracts. Arrows pointing to reporter-positive axons in ventral white matter indicate probable reticulospinal (RtST) and vestibulospinal (VST), and an unknown descending projection (?) tracts rostral to the injury, and spinothalamic (STT) and possible dorsal spinocerebellar [DSCT(?)] below the injury (thoracic and lumbar sections). D, Neurons in Clarke’s column ipsilateral to the hemisection. E, F, Large and small, respectively, putative spinothalamic tract neurons contralateral to the hemisection. Arrows in E, F indicate commissural axons; cc, central canal.

  • Figure 9.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 9.

    Hemisection-induced recombination in supraspinal neurons one week after injury. A, Paraventricular hypothalamic nucleus, descending part. B, Red nucleus. C, Vestibulospinal nucleus (the genu of the facial nerve is indicated by VII). D, Reticulospinal neurons (RtS) and raphespinal neurons (arrow), and the rubrospinal tract (RST). E, Reporter-expressing axons in the medial longitudinal fasciculus (conveying descending projections of reticulospinal and vestibulospinal axons). F, Examples of ATF3-positive, tdtomato-positive and tdtomato-negative neurons in the paraventricular hypothalamic nucleus (PHN), red nucleus (RN), vestibulospinal nucleus (VSN), and reticulospinal neurons (RtS).

Back to top

In this issue

eneuro: 6 (2)
eNeuro
Vol. 6, Issue 2
March/April 2019
  • Table of Contents
  • Index by author
  • Ed Board (PDF)
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
An ATF3-CreERT2 Knock-In Mouse for Axotomy-Induced Genetic Editing: Proof of Principle
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
An ATF3-CreERT2 Knock-In Mouse for Axotomy-Induced Genetic Editing: Proof of Principle
Seth D. Holland, Leanne M. Ramer, Stephen B. McMahon, Franziska Denk, Matt S. Ramer
eNeuro 28 March 2019, 6 (2) ENEURO.0025-19.2019; DOI: 10.1523/ENEURO.0025-19.2019

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
An ATF3-CreERT2 Knock-In Mouse for Axotomy-Induced Genetic Editing: Proof of Principle
Seth D. Holland, Leanne M. Ramer, Stephen B. McMahon, Franziska Denk, Matt S. Ramer
eNeuro 28 March 2019, 6 (2) ENEURO.0025-19.2019; DOI: 10.1523/ENEURO.0025-19.2019
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
    • Synthesis
    • Author Response
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • Activating Transcription Factor 3
  • gene editing
  • peripheral nerve
  • Schwann cells
  • sensory neurons
  • spinal cord injury

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Methods/New Tools

  • Superficial Bound of the Depth Limit of Two-Photon Imaging in Mouse Brain
  • A Toolbox of Criteria for Distinguishing Cajal–Retzius Cells from Other Neuronal Types in the Postnatal Mouse Hippocampus
  • Assessment of Spontaneous Neuronal Activity In Vitro Using Multi-Well Multi-Electrode Arrays: Implications for Assay Development
Show more Methods/New Tools

Novel Tools and Methods

  • Superficial Bound of the Depth Limit of Two-Photon Imaging in Mouse Brain
  • A Toolbox of Criteria for Distinguishing Cajal–Retzius Cells from Other Neuronal Types in the Postnatal Mouse Hippocampus
  • Assessment of Spontaneous Neuronal Activity In Vitro Using Multi-Well Multi-Electrode Arrays: Implications for Assay Development
Show more Novel Tools and Methods

Subjects

  • Novel Tools and Methods
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2026 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.